NCT01930175View on ClinicalTrials.gov

Study of Efficacy and Safety of VAY736 in Patients With Pemphigus Vulgaris

PHASE2TerminatedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

December 18, 2013

Primary Completion Date

September 25, 2019

Study Completion Date

September 25, 2019

Conditions
Pemphigus Vulgaris
Interventions
DRUG

VAY736

DRUG

Placebo

Trial Locations (5)

1040

Novartis Investigative Site, Vienna

1431

Novartis Investigative Site, Sofia

10002

Novartis Investigative Site, Taipei

19104

Novartis Investigative Site, Philadelphia

27516

Novartis Investigative Site, Chapel Hill

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY